Archimedic Blog
The Latest Medtech Insights from Archimedic.
Most medical device companies operate using the waterfall method. But most medical device companies don’t operate as quickly as they could or should.
The waterfall goes like this:
- Write down your ...
What is your manufacturing strategy? There are several options to consider. Sometimes it makes sense to engage a large CMO early, whereas other times it makes sense to launch manufacturing with a smal...
Most companies run product development under the Hero model. This is where a highly experienced medical device developer gives play-by-play direction on product development activities. This can work s...
Medtech teams have a critical decision to make at the early stages. Should the strategy be to build a robust in-house team or leverage outsourced experts to achieve medtech milestones. Here's an hones...
When developing a new medical product, have you ever heard a medtech investor or exec say, "Take your time. We'll get there when we get there.."? Us either.
There's always urgency. And for good reaso...
Most companies avoid primary market research. They believe that in-house tribal knowledge is enough to make the key product and business decisions. Research would just tell the team what they already ...
The prospect of obtaining a new reimbursement code and corresponding coverage for a new medical device is daunting. So much so that many investors simply refuse to pursue medical device opportunities ...
Happy Wednesday to 602 motivated medtech business leaders. Here's one short tip on how to refine your medtech strategy.
In this week's issue, I'm going to break down the #1 thing that prevents medt...
Here are 4 steps on how to clearly define the clinical outcome that compels adoption of your new medical device.
If you are growing a medical device business, a big part of your mission is to impro...
Consider a medical device startup, facing a critical market decision: Should the company go big, aiming for the $1B market out of the gate? Or should the company go small, proving value with an initia...
True story. A medical device manufacturer developed an at-home wearable defibrillator for populations at high risk of sudden cardiac death. This device was intended to be a bridge – worn for approxima...
Clinical use is a significant milestone for most medical device companies. Investors often see this milestone as a significant de-risking activity – one that can come with valuation bumps and subseque...
Join the conversation
Drop your email in the form below, and you will receive our medtech articles as soon as they're published.